Jane Street
CGON icon

Jane Street’s CG Oncology CGON Stock Holding History

Jane Street’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.86M Sell
57,100
-9,300
-14% -$527K ﹤0.01% 3920
2025
Q4 		$2.76M Buy
66,400
+56,000
+538% +$2.32M ﹤0.01% 4192
2025
Q3 		$419K Buy
+10,400
New +$302K ﹤0.01% 8225

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jane Street's CGON Position: Q1 2026 in Review

Jane Street opened a new position in CG Oncology (CGON) in Q1 2026: 3,097 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #10034 among its holdings. This is a return to the name: Jane Street previously reported a position in CGON as recently as Q4 2024.

Jane Street first reported a position in CGON in Q1 2024 and has held it in 5 quarters since. The position peaked at $7.39M in Q3 2024. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Jane Street held 3,097 shares of CG Oncology worth $210K as of Q1 2026.
  • CG Oncology was a new Jane Street position in Q1 2026.
  • CG Oncology made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10034 holding.
  • Jane Street first reported a position in CG Oncology in Q1 2024 and has held it in 5 quarters since.
  • Jane Street's CG Oncology position peaked at $7.39M in Q3 2024.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.